ProMIS Neurosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS (Tables)

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2024

FAIR VALUE MEASUREMENTS

Summary of major categories of assets and liabilities measured at fair value on a recurring basis


		As of September 30, 2024
		Level 1			Level 2				Level 3		Total
Assets:
Short-term investments		$	32,358		$	—		$	—		$	32,358
Total assets measured at fair value		$	32,358		$	—		$	—		$	32,358
Liabilities:
Share-based compensation liability		$	—		$	—		$	340,090		$	340,090
Warrant liability		$	—		$	—		$	14,262,138		$	14,262,138
Total liabilities measured at fair value		$	—		$	—		$	14,602,228		$	14,602,228


		As of December 31, 2023
		Level 1			Level 2				Level 3		Total
Assets:
Short-term investments		$	32,358		$	—		$	—		$	32,358
Total assets measured at fair value		$	32,358		$	—		$	—		$	32,358
Liabilities:
Share-based compensation liability		$	—		$	—		$	422,002		$	422,002
Warrant liability			—			—			94,185			94,185
Total liabilities measured at fair value		$	—		$	—		$	516,187		$	516,187